Abeona Therapeutics, Inc. (ABEO)
4.91
-0.21
(-4.10%)
USD |
NASDAQ |
Apr 10, 16:00
4.92
+0.01
(+0.20%)
After-Hours: 20:00
Abeona Therapeutics Cash from Investing (Quarterly) : 9.554M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 55.42M |
| Plus Therapeutics, Inc. | -1.077M |
| Atossa Therapeutics, Inc. | -0.007M |
| Cell Source, Inc. | 0.00 |
| Kiora Pharmaceuticals, Inc. | 5.349M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.95M |
| Cash from Financing (Quarterly) | 3.614M |
| Free Cash Flow | -84.30M |
| Free Cash Flow Per Share (Quarterly) | -0.3471 |
| Free Cash Flow to Equity (Quarterly) | -19.97M |
| Free Cash Flow to Firm (Quarterly) | -18.23M |
| Free Cash Flow Yield | -30.43% |